Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,527 INR
Change Today +17.55 / 1.16%
Volume 104.5K
TRP On Other Exchanges
As of 7:06 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

torrent pharmaceuticals ltd (TRP) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/1/15 - 1,720
52 Week Low
10/20/14 - 810.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

torrent pharmaceuticals ltd (TRP) Related Businessweek News

No Related Businessweek News Found

torrent pharmaceuticals ltd (TRP) Details

Torrent Pharmaceuticals Limited manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally. The company offers its products in the therapeutic areas of cardiovascular, central nervous system, gastrointestinal, anti-infective, diabetology, pain management, women health, wound care, nutraceuticals, nephrology, and oncology in the form of tablets, capsules, and parenterals. Its active pharmaceutical ingredients comprise nicorandil, risperidone, venlafaxine hydrochloride, ropinarole hydrochloride, duloxetine hydrochloride, ormeloxifen hydrochloride, nebivolol hydrochloride, lamotrigine, sertraline hydrochloride, and clopidogrel bisulphate, as well as atomoxatine hydrochloride, rivastigmine hydrogen tartrate, and esomeprazole sodium. Torrent Pharmaceuticals Limited also provides contract manufacturing services primarily for human insulin. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Private Limited.

11,047 Employees
Last Reported Date: 07/1/15
Founded in 1959

torrent pharmaceuticals ltd (TRP) Top Compensated Officers

Executive Chairman, Managing Director, Member...
Total Annual Compensation: --
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 31.9M
Vice President of Legal, Compliance Officer a...
Total Annual Compensation: 6.8M
Director of Research & Development, Whole-Tim...
Total Annual Compensation: 44.7M
Vice President of Procurement
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

torrent pharmaceuticals ltd (TRP) Key Developments

Torrent Pharmaceuticals Ltd., Board Meeting, Oct 08, 2015

Torrent Pharmaceuticals Ltd., Board Meeting, Oct 08, 2015. Agenda: To approve the scheme of amalgamation of Zyg Pharma Private Limited with Torrent Pharmaceuticals Limited and their respective shareholders and creditors.

Cipla Reportedly Mulls Acquisition Of Stake In Kremers

Cipla Limited (NSEI:CIPLA) reportedly seeking acquisition of stakes in Kremers Urban Pharmaceuticals Inc. from UCB S.A. (ENXTBR:UCB). Cipla has emerged as the sole Indian contender for Kremers Urban Pharmaceuticals Inc. which is pegged at around $1.3 billion. "Cipla is the only Indian bidder for KU but it is pitted against a few powerful private equity players. It also depends on whether Cipla is prepared to shell out a large amount in a single bid," an industry watcher told Economic Times. Lupin Limited (BSE:500257) and Torrent Pharmaceuticals Ltd. (BSE:500420) were named as the other two Indian parties that had initially shown interest but eventually opted out. One of them is China's conglomerate China Grand Group. UCB floated the divestiture of Kremers Urban in 2014. In response to questions from ET, a Cipla spokesperson said the company does not comment on any product or partner discussions. Kremers had sales of $463 million in 2014.

Torrent Pharmaceuticals Ltd. Reports Audited Standalone and Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Torrent Pharmaceuticals Ltd. reported audited standalone and unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, on standalone basis, the company reported net sales were INR 18,100 million compared to INR 8,960 million a year ago. Net income from operation was INR 18,670 million compared to INR 9,170 million a year ago. Profit from operations before other income and finance costs was INR 11,200 million compared to INR 3,550 million a year ago. Profit from ordinary activities was INR 11,390 million compared to INR 3,870 million a year ago. Net profit was INR 8,300 million or INR 49.07 per basic and diluted share compared to INR 3,050 million or INR 18.01 per basic and diluted share a year ago. For the quarter, on consolidated basis, the company reported Net Sales were INR 18,860 million compared to INR 10,920 million a year ago. Profit from operations before other income and finance cost was INR 8,500 million compared to INR 3,240 million a year ago. Profit from ordinary activities before tax was INR 8,590 million against INR 3,490 million a year ago. Net profit was INR 4,490 million or INR 26.54 per basic and diluted share compared to INR 2,560 million or INR 15.12 per basic and diluted share a year ago. Revenue was INR 19,470 million compared to INR 11,140 million a year ago. EBITDA was INR 9,740 million compared to INR 3,800 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRP:IN 1,526.85 INR 0.00

TRP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Divi's Laboratories Ltd 1,095 INR +5.90
Ipca Laboratories Ltd 724.10 INR 0.00
Jubilant Life Sciences Ltd 374.45 INR 0.00
Piramal Enterprises Ltd 922.55 INR +11.75
Wockhardt Ltd 1,549 INR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation TRP Industry Range
Price/Earnings 26.8x
Price/Sales 4.6x
Price/Book 10.2x
Price/Cash Flow 21.6x
TEV/Sales 4.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TORRENT PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at